A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers.

被引：0
|
作者：
Gebbia, N
Verderame, F
Di Leo, R
Santangelo, D
Cicero, G
Valerio, MR
Arcara, C
Badalamenti, G
Fulfaro, F
Carreca, I
机构：
[1] Dept Oncol, Palermo, Sicily, Italy
[2] Azienda Osp, Sciacca, Italy
[3] Dept Expt & Clin Onc, Palermo, Sicily, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340S / 340S
页数：1
相关论文
共 50 条
  • [31] Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
    Gruenberger, Birgit
    Schueller, Johannes
    Heubrandtner, Ute
    Wrba, Fritz
    Tamandl, Dietmar
    Kaczirek, Klaus
    Roka, Rudolf
    Pircher, Sandra Freimann
    Gruenberger, Thomas
    LANCET ONCOLOGY, 2010, 11 (12): : 1142 - 1148
  • [32] Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: A single-institution experience
    Manzione, Luigi
    Romano, Rosangela
    Germano, Domenico
    ONCOLOGY, 2007, 73 (5-6) : 311 - 315
  • [33] Phase II study of gemcitabine, oxaliplatin in combination with bevacizumab (GEMOX-B) in patients with unresectable or metastatic biliary tract and gallbladder cancers
    Clark, J. W.
    Meyerhardt, J. A.
    Sahani, D. V.
    Namasivayam, S.
    Abrams, T. A.
    Stuart, K.
    Bhargava, P.
    Blaszkowsky, L. S.
    Jain, S. R.
    Zhu, A. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer
    Possinger, K
    Kaufmann, M
    Coleman, R
    Stuart, NSA
    Helsing, M
    Ohnmacht, U
    Arning, M
    ANTI-CANCER DRUGS, 1999, 10 (02) : 155 - 162
  • [35] Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park, Byung Kyu
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Kim, Kyung Sik
    Choi, Jin-Sub
    Lee, Woo Jung
    Song, Si Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 999 - 1003
  • [36] A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim, ST
    Park, JO
    Lee, J
    Lee, KT
    Lee, JK
    Choi, SH
    Heo, JS
    Park, YS
    Kang, WK
    Park, K
    CANCER, 2006, 106 (06) : 1339 - 1346
  • [37] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
  • [38] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Toda, Nobuo
    Yasuda, Ichiro
    Hasebe, Osamu
    Maetani, Iruru
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107
  • [39] Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
    Markussen, Alice
    Jensen, Lars Henrik
    Diness, Laura Vittrup
    Larsen, Finn Ole
    CANCERS, 2020, 12 (07) : 1 - 10
  • [40] A phase II study of ramucirumab for advanced, pre-treated biliary cancers.
    Mizrahi, Jonathan
    Javle, Milind M.
    Xiao, Lianchun
    Varadhachary, Gauri R.
    Raghav, Kanwal Pratap Singh
    Wolff, Robert A.
    Shroff, Rachna T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345